KESIMPTA
Solution for injection in pre-filled pen, 20 mg
RxActive license
Active substance (INN)
ofatumumab
Pharmaceutical form
Pharmaceutical formSolution for injection in pre-filled pen
Strength20 mg
PackagingUkupno 1 napunjeni injekcioni pen sa 0.4 ml rastvora za injekciju u kartonskoj kutiji
ManufacturerNovartis Pharma Stein AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L04AG12)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateAugust 26, 2022
Source: CInMED register